Sugi Predict

Sugi Predict / Compounds / SCHEMBL6733161

SCHEMBL6733161

SCHEMBL6733161

CS(=O)(=O)c1cc(F)c(-c2nc(C(F)(F)F)[nH]c2-c2cccc(Cl)c2)cc1F

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 4/20 0.40
▸ NR1H3 Q13133 4/20 0.40
▸ RAB9A P51151 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PTGS2 P35354 2/20 0.39
▸ IDO1 P14902 1/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ TGFBR1 P36897 2/20 0.36
▸ TGFBR2 P37173 2/20 0.36
▸ SCD O00767 1/20 0.36
▸ BRAF P15056 5/20 0.35
▸ ATM Q13315 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CRHBP P24387 1/20 0.35
▸ CRHR2 Q13324 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ SCN9A Q15858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6735914 0.91 BRAF (0.38) NR1H2NR1H3PTGS2ESR1ESR2
SCHEMBL6729594 0.89 MAPK14 (0.42) NR1H2NR1H3KMT2APTGS2ESR1
SCHEMBL6734567 0.89 SDHB (0.42) NR1H2NR1H3RAB9APTGS2ESR1
SCHEMBL6729150 0.89 PTGS2 (0.42) NR1H2NR1H3PTGS2ESR1ESR2
SCHEMBL6739929 0.88 ESR1 (0.48) NR1H2NR1H3RAB9AKMT2APTGS2
SCHEMBL6734391 0.88 NR1H2 (0.40) NR1H2NR1H3KMT2APTGS2ESR1
SCHEMBL6735451 0.87 PTGS2 (0.38) NR1H2NR1H3PTGS2ESR1ESR2
SCHEMBL6733692 0.87 SCN9A (0.38) NR1H2NR1H3PTGS2ESR1ESR2
SCHEMBL6729038 0.87 TGFBR1 (0.43) RAB9AKMT2APTGS2ESR1ESR2
SCHEMBL6733585 0.85 PTGS2 (0.42) NR1H2NR1H3PTGS2ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-07-15 — — US disclosed
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 — — US disclosed
US-6673818-B2 TREATING CYCLOOXYGENASE-2 MEDIATED DISORDERS, SUCH AS ARTHRITIS, PAIN, FEVER AND CANCER PHARMACIA CORPORATION 2004-01-06 — — US disclosed
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-08-07 — — US disclosed
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-02-13 — — US disclosed
EP-1251126-A2 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation Pharmacia Corporation (US) 2002-10-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 NR1H2 173/4885NR1H3 299/4885RAB9A 4116/4885
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 NR1H2 173/4885NR1H3 299/4885RAB9A 4116/4885
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 NR1H2 173/4885NR1H3 299/4885RAB9A 4116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.